← Every applicant
Sciegen Pharms FDA Approvals
31 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| BRIVARACETAMNew drugJul 1, 2026TABLET, ORAL |
| TOFACITINIB CITRATENew drugJun 25, 2026TABLET, EXTENDED RELEASE, ORAL |
| HYDROXYZINE HYDROCHLORIDENew drugJun 11, 2026SYRUP, ORAL |
| VALSARTAN AND HYDROCHLOROTHIAZIDENew drugApr 23, 2026TABLET, ORAL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDENew drugMar 31, 2026TABLET, ORAL |
| TICAGRELORNew drugOct 28, 2025TABLET, ORAL |
| GABAPENTINNew drugSep 19, 2025TABLET, ORAL |
| RIVAROXABANNew drugJul 31, 2025TABLET, ORAL |
| METRONIDAZOLENew drugDec 31, 2024GEL, VAGINAL |
| EZETIMIBE AND SIMVASTATINNew drugDec 10, 2024TABLET, ORAL |
| GLYCOPYRROLATENew drugOct 7, 2024SOLUTION, ORAL |
| LITHIUM CITRATENew drugMar 18, 2024SYRUP, ORAL |
| CLOTRIMAZOLENew drugOct 16, 2023SOLUTION, TOPICAL |
| NAPROXEN AND ESOMEPRAZOLE MAGNESIUMNew drugOct 11, 2023TABLET, DELAYED RELEASE, ORAL |
| PHYTONADIONENew drugJul 28, 2023TABLET, ORAL |
| DILTIAZEM HYDROCHLORIDENew drugApr 6, 2023TABLET, EXTENDED RELEASE, ORAL |
| DILTIAZEM HYDROCHLORIDENew drugSep 23, 2022TABLET, ORAL |
| PREGABALINNew drugSep 14, 2022TABLET, EXTENDED RELEASE, ORAL |
| PIRFENIDONENew drugAug 1, 2022TABLET, ORAL |
| PIRFENIDONENew drugAug 1, 2022CAPSULE, ORAL |
| LACOSAMIDENew drugMar 17, 2022TABLET, ORAL |
| METFORMIN HYDROCHLORIDENew drugFeb 22, 2022TABLET, EXTENDED RELEASE, ORAL |
| LEVOCARNITINENew drugNov 10, 2021SOLUTION, ORAL |
| VALSARTANNew drugOct 27, 2021TABLET, ORAL |
| CARBIDOPA AND LEVODOPANew drugOct 5, 2021TABLET, EXTENDED RELEASE, ORAL |
| LEVETIRACETAMNew drugJun 11, 2021TABLET, ORAL |
| POTASSIUM CHLORIDENew drugMay 21, 2021SOLUTION, ORAL |
| CARBIDOPA AND LEVODOPANew drugMay 7, 2021TABLET, ORAL |
| METFORMIN HYDROCHLORIDENew drugApr 16, 2021TABLET, EXTENDED RELEASE, ORAL |
| LISINOPRILNew drugMar 4, 2021TABLET, ORAL |
| DROXIDOPANew drugFeb 18, 2021CAPSULE, ORAL |